Clinical Trial Update: Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating autologous mesenchymal stem cells in patients with Multiple System Atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Yonsei University | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED